Sanon, Vani P

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin. [electronic resource] - Therapeutics and clinical risk management 2017 - 603-611 p. digital

Publication Type: Journal Article; Review

1176-6336

10.2147/TCRM.S97619 doi